| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,481 |
8,552 |
$367K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,421 |
3,191 |
$239K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,697 |
3,430 |
$231K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,659 |
3,167 |
$226K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,294 |
3,951 |
$180K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,167 |
2,025 |
$150K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,490 |
6,749 |
$97K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,253 |
1,126 |
$95K |
| 92552 |
|
5,690 |
4,932 |
$83K |
| 96160 |
|
10,478 |
6,277 |
$52K |
| 87428 |
|
813 |
784 |
$34K |
| 96127 |
|
7,749 |
4,662 |
$31K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
827 |
720 |
$22K |
| 99384 |
|
246 |
198 |
$21K |
| 99173 |
|
6,971 |
6,102 |
$21K |
| 99215 |
Prolong outpt/office vis |
185 |
180 |
$18K |
| 99383 |
|
156 |
107 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
287 |
219 |
$11K |
| 99381 |
|
167 |
142 |
$10K |
| 96161 |
|
2,719 |
2,142 |
$10K |
| 83655 |
|
1,151 |
1,060 |
$7K |
| 85018 |
|
2,757 |
2,486 |
$5K |
| 81002 |
|
2,122 |
1,795 |
$5K |
| 92551 |
|
686 |
676 |
$4K |
| 36416 |
|
3,591 |
3,176 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
368 |
304 |
$4K |
| 99382 |
|
51 |
38 |
$4K |
| 90461 |
|
4,672 |
4,205 |
$4K |
| 90671 |
|
738 |
685 |
$4K |
| 90651 |
|
419 |
345 |
$4K |
| 80061 |
Lipid panel |
1,517 |
1,294 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,836 |
1,617 |
$3K |
| 0072A |
|
85 |
78 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
364 |
339 |
$3K |
| 90670 |
|
1,850 |
1,699 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
60 |
38 |
$2K |
| 0002A |
|
55 |
36 |
$2K |
| 90680 |
|
1,496 |
1,382 |
$2K |
| 0001A |
|
51 |
39 |
$2K |
| 0071A |
|
51 |
47 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
263 |
254 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
491 |
465 |
$2K |
| 90698 |
|
1,346 |
1,251 |
$1K |
| 90686 |
|
3,127 |
2,853 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
105 |
71 |
$1K |
| 0082A |
|
21 |
18 |
$793.44 |
| 90734 |
|
191 |
175 |
$757.86 |
| 90633 |
|
1,037 |
966 |
$714.77 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
48 |
28 |
$550.54 |
| 90480 |
|
12 |
12 |
$393.50 |
| 96380 |
|
15 |
14 |
$246.27 |
| 90710 |
|
76 |
63 |
$224.94 |
| 90716 |
|
58 |
49 |
$160.00 |
| 94664 |
|
12 |
12 |
$154.58 |
| 90744 |
|
681 |
635 |
$151.76 |
| 90656 |
|
39 |
39 |
$138.11 |
| 84443 |
Thyroid stimulating hormone (TSH) |
412 |
358 |
$83.83 |
| 99174 |
|
13 |
12 |
$56.74 |
| 84439 |
|
133 |
107 |
$40.64 |
| 80053 |
Comprehensive metabolic panel |
740 |
644 |
$21.25 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
697 |
602 |
$19.60 |
| 90648 |
|
46 |
41 |
$14.60 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
1,254 |
1,195 |
$11.88 |
| 99051 |
|
17 |
17 |
$10.00 |
| 90697 |
|
376 |
345 |
$0.70 |
| 91300 |
|
210 |
136 |
$0.49 |
| 87077 |
|
87 |
85 |
$0.14 |
| 90619 |
|
35 |
27 |
$0.05 |
| G9920 |
Screening performed and negative |
2,308 |
2,014 |
$0.00 |
| 83718 |
|
97 |
83 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
1,018 |
926 |
$0.00 |
| 90661 |
|
465 |
438 |
$0.00 |
| 82465 |
|
97 |
83 |
$0.00 |
| 90700 |
|
72 |
67 |
$0.00 |
| 91308 |
|
32 |
19 |
$0.00 |
| 83721 |
|
154 |
130 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
27 |
24 |
$0.00 |
| 90707 |
|
33 |
26 |
$0.00 |
| 90620 |
|
80 |
72 |
$0.00 |
| 84478 |
|
97 |
83 |
$0.00 |
| 91307 |
|
151 |
129 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
27 |
24 |
$0.00 |